Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Type 2 diabetic patients (HBA1c >7%) with generalized chronic periodontitis clinically diagnosed with the presence of pocket >=5 mm and probing attachment loss of 4 mm or more in at least 2 different quadrants which bleed on probing . 2.Subjects who are on oral hypo-glycemic agents or insulin injections and diet in combination or separately. They should be diabetic for >1 year, are on the same type and dose of diabetic medication for the past 6 months 3.Patients who are in good physical condition and do not have any major illness or serious medical condition or transmissible disease. 4.Patients willing to give informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with known history of allergies especially to CHX. 2.History of systemic antibiotic usage over the previous 4 months. 3.Pregnant or lactating women. 4.Non-surgical periodontal treatment within the past 6 months 5.Use of nonsteroidal anti-inflammatory drugs. 6.Use of immunosuppressive medications. 7.Subjects with intake of supplemental Ascorbic acid. 8.Subjects with history of prolonged drug use that interfere with coagulation system, e.g Coumarin derivatives. 9.History of severe cardiovascular, haematological, renal, hepatic and immunological disorders. 10.Patients who are smokers and alcoholics. 11.Patient not willing to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of clinical parameters in diabetic patients suffering from chronic periodontitis on home care maintenance regime comprising of twice daily sub-gingival home irrigation using 0.06% chlorhexidine gluconate along with powered toothbrushes vis a vis those on routine home care maintenance regime comprising of twice daily mouth rinsing with 0.12% chlorhexidine gluconate along with manual tooth brushes. Timepoint: baseline 1 month 2 month 4 month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Comparative evaluation of glycemic control between the study groups. 2. Comparative evaluation of inflammatory markers between the study groups. 3. Comparative evaluation of microbiological profiling of the study groups. Timepoint: baseline 4 months | — |
Countries
India
Contacts
Panjab University